Cost of strategies after myocardial infarction (COSTAMI): A multicentre, international, randomized trial for cost-effective discharge after uncomplicated myocardial infarction

European Heart Journal

Volumn 24, Issue 18, 2003, Pages 1630-1639

  Desideri, Alessandro ^a,j   Fioretti, Paolo Maria ^b   Cortigiani, Lauro ^c   Gregori, Dario ^b   Coletta, Claudio ^d   Vigna, Carlo ^e   Tota, Francesco ^f   Rambaldi, Riccardo ^g   Bax, Jeroen ^h   Celegon, Leopoldo ^a   Bigi, Riccardo ^a   Picano, Eugenio ⁱ  

^a CARDIOVASCULAR RESEARCH FOUNDATION   (Italy)

^b IRCAB Foundation   (Italy)

^c CAMPO DI MARTE HOSPITAL   (Italy)

^d SPIRITO SANTO HOSPITAL   (Italy)

^e CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^f GENERAL HOSPITAL   (Italy)

^g GENERAL HOSPITAL   (Italy)

^h LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^j S Giacomo Hospital   (Italy)

more..

Author keywords

Cost benefit analysis; Early discharge; Myocardial Infarction

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; EXERCISE ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEALTH CARE COST; HEART MUSCLE ISCHEMIA; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; STRESS ECHOCARDIOGRAPHY; SYMPTOMATOLOGY; TREATMENT PLANNING;

CARDIOTONIC AGENTS; COST-BENEFIT ANALYSIS; DIPYRIDAMOLE; DOBUTAMINE; ECHOCARDIOGRAPHY, STRESS; FEMALE; HEALTH RESOURCES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; QUALITY OF LIFE; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 0141510068     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-668X(03)00308-7     Document Type: Article

References (31)

1. Lave JR, Leinhardt S. The cost and length of a hospital stay. Inquiry 1976;13:327-43.
2. Newby L, Califf R, Guerci A et al. Early discharge in the thrombolytic era: an analysis of criteria for uncomplicated infarction from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) trial. J Am Coll Cardiol 1996;27:625-32.
3. Ryan T, Antman E, Brooks N et al. ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation 1999;100:1016-30.
4. Arnese M, Fioretti PM, Cornel J et al. Akinesis becoming dyskinesis during high-dose dobutamine stress echocardiography: a marker of myocardial ischemia or a mechanical phenomenon? Am J Cardiol 1994;73:896-9.
5. Picano E, Landi P, Bolognese L et al. Prognostic value of dipyridamole echocardiography early after uncomplicated myocardial infarction: a large scale, multicenter trial. Am J Med 1993;6:608-18.
6. Picano E, Mathias W Jr., Pingitore A et al. Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, large scale, multicenter Trial. Lancet 1994;344:1190-2.
7. Lim L, Valenti L, Knapp J et al. A self administered quality of life questionnaire after acute myocardial infarction. J Clin Epidemiol 1993;46:1249-56.
8. Locallio AR, Berlin JA, Ten Have TR et al. Adjustments for center in multicenter studies: an overview. Ann Intern Med 2001;135:112-23.
9. Lindstrom MJ, Bates DM. Nonlinear mixed effects models for repeated measures data. Biometrics 1990;46:673-87.
10. Wei LJ, Lin D, Weissfeld L. Regression analysis of multivariate incomplete failure time data by modeling marginal distributions. JASA 1989;84:1065-73.
11. Liang K, Zeger SL. Longitudinal Data Analysis using generalized linear models. Biometrika 1986;73:13-22.
12. Statistical Science, S-PLUS Guide to statistical and mathematical analysis, Version 3.3. Seattle: Statsci, Mathsoft Inc; 1995.
13. Mark DB, Sigmon K, Topol EJ et al. Identification of acute myocardial infarction patients suitable for early hospital discharge after aggressive interventional therapy: results from the Thrombolysis and Angioplasty in acute myocardial infarction Registry. Circulation 1991; 83:1186-91.
14. Sanz G, Betriu A, Oller G. Feasibility of early discharge after acute Q wave myocardial infarction in patients not receiving thrombolytic treatment. J Am Coll Cardiol 1993;22:1795-801.
15. Parsons R, Jamrozik K, Hobbs M et al. Early identification of patients at low risk of death after myocardial infarction and potentially suitable for early hospital discharge. BMJ 1994;308:1006-10.
16. Bogarty P, Dumont S, O'Hara G et al. Randomized Trial of a noninvasive strategy to reduce hospital stay for patients with low-risk myocardial infarction. J Am Coll Cardiol 2001;37:1289-96.
17. Verani M. Risk stratifying patients who survive an acute myocardial infarction. J Nucl Cardiol 1998;5:96-108.
18. Madsen JK, Grande P, Saunamaki K et al. Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI). DANish trial in Acute Myocardial Infarction. Circulation 1997;96:748-55.
19. Volpi A, De Vita C, Franzosi MG, the Ad hoc Working Group of the Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto (GISSI)-2 Data Base et al. Determinants of 6 month mortality in survivors of myocardial infarction after thrombolysis. Results of the GISSI 2 data base. Circulation 1993;88:416-29.
20. Boden W, O'Rourke R, Crawford M et al. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. N Engl J Med 1998;338:1785-92.
21. Barnett P, Chen S, Boden W et al. Cost-effectiveness of a conservative, ischemia-guided management strategy after non-Q-wave myocardial infarction. Results of a randomized trial. Circulation 2002; 105:680-4.
22. Desideri A, Bigi R, Suzzi G et al. Stress echocardiography and exercise electrocardiography for risk stratification after non Q wave uncomplicated myocardial infarction. Am J Cardiol 1999;84:739-41.
23. Bigi R, Galati A, Desideri A et al. Incremental prognostic value of stress echocardiography as adjunctive test to exercise electrocardiography following uncomplicated myocardial infarction. Heart 2001; 85:417-23.
24. Sicari R, Landi P, Picano E, on behalf of the EPIC (Echo Persantine International Cooperative) and EDIC (Echo Dobutamine International Cooperative) Study Groups et al. Exercise-electrocardiography and/or pharmacological stress echocardiography for noninvasive risk stratification early after uncomplicated myocardial infarction: a prospective international large scale multicenter study. Eur Heart J 2002;23:1030-7.
25. Picano E, Marini C, Pirelli S et al. Safety of intravenous high-dose dipyridamole echocardiography. Am J Cardiol. 1992;70:252-8.
26. Cortigiani L, Zanetti L, Bigi R et al. Safety and feasibility of dobutamine and dipyridamole stress echocardiography in hypertensive patients. J Hypertens 2002;20:1423-9.
27. Chiarella F, Domenicucci S, Bellotti P. Dipyridamole echocardiographic test performed 3 days after an acute myocardial infarction: feasibility, tolerability, safety and in-hospital prognostic value. Eur Heart J 1994;15:842-50.
28. Brown KA, Heller GV, Landin RS et al. Early dipyridamole (99m) Tc-sestamibi single photon emission computed tomographic imaging 2 to 4 days after acute myocardial infarction predicts in-hospital and postdischarge cardiac events: comparison with submaximal exercise imaging. Circulation 1999;100:2060-6.
29. Van Daete ME, McNeill AJ, Fioretti PM et al. Prognostic value of dipyridamole sestamibi single-photon emission computed tomography and dipyridamole stress echocardiography for new cardiac events after an uncomplicated myocardial infarction. J Am Soc Echocardiogr 1994;7:370-80.
30. Picano E. Stress echocardiography: a historical perspective. J Am Med 2003;14(1):1-6.
31. Lattanzi F, Picano E, Bolognese L et al. Inhibition of dipyridamole-induced ischemia by antianginal therapy in humans. Correlation with exercise electrocardiography. Circulation 1991;83:1256-62.